The Ontario Medical Association (OMA) has issued a warning that on-going challenges posed by the COVID-19 pandemic threaten the drug supply in Canada, and are calling on governments across the country to work towards enhancing Canada’s domestic drug manufacturing capacity. China and India supply most of the drug ingredients used in North America. Some commonly used drugs that are under strain include propofol, ketamine, succinylcholine and fentanyl. Other stakeholders, including the Critical Drugs Coalition, have expressed similar concerns.